Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This clinical research intervention involves the transfusion of packed red blood cells (PRBCs) to anemic patients (hemoglobin <10 g/dL) who have suffered an aneurysmal subarachnoid hemorrhage (aSAH). Conducted by the Washington University School of Medicine, the study (NCT00968227) investigates the therapeutic potential of RBC transfusion to improve cerebral oxygen delivery (DO2) and brain metabolism. By increasing the concentration of hemoglobin and the arterial oxygen content, the intervention aims to prevent or reverse delayed cerebral ischemia (DCI), a common complication of SAH where reduced blood flow leads to secondary brain injury. The research specifically utilizes PET imaging to measure changes in the oxygen extraction fraction (OEF) and regional cerebral blood flow following the administration of approximately one unit of PRBCs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on red blood cell transfusion (Washington University School of Medicine).